Ireland· IE-PA-EU/1/12/805/003-004
Amyvid 1,900 MBq/mL solution for injection
A florbetapir (18f) product containing florbetapir (18f), registered in Ireland by Eli Lilly Nederland B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Florbetapir (18f) is registered in 11 of 19 countries.
Countries holding a registration under ATC V09AX05 (florbetapir (18f)), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Florbetapir (18f) · ATC V09AX05
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Florbetapir (18f)
- Manufacturer
- Eli Lilly Nederland B.V.
- Country
- Ireland (IE)
- ATC code
- V09AX05
- ATC class
- Florbetapir (18F)
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/12/805/003-004
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Florbetapir (18f) in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainAMYVID 1.900 MBq/ml solucion inyectableEli Lilly Nederland B.V.
- CzechiaAMYVIDEli Lilly Nederland B.V., Utrecht
- SwedenAmyvid 1900 MBq/ml Injektionsvätska, lösningEli Lilly Nederland B.V.
- FinlandAmyvidEli Lilly Nederland B.V.
- Japanフロルベタピル（１８Ｆ）ＰＤＲファーマ
- United StatesAmyvidEli Lilly and Company
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Amyvid
- Liechtenstein · Amyvid
- Norway · Amyvid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1409ab03-53f5-45aa-a03c-ba6b5a35cd30 GET /v1/drugs/1409ab03-53f5-45aa-a03c-ba6b5a35cd30?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"V09AX",
"V09AX05"
],
"strength": null,
"pa_number": "EU/1/12/805/003-004",
"substances": [
"Florbetapir (18f)"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": null,
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about florbetapir (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.